JAZZ News and Press, Jazz Pharmaceuticals plc From 04/27/21

The Medicinal  Cannabis Industry In May As the cannabis industry grows the medicinal use of marijuana will play a big role in the future of the market. According to BDSA global cannabis sales reached an estimated $21.3 billion in 2020 an increase of 48% compared to 2019. By 2026 BD...

Merger activity remained steady last week with six new deals announced. Kansas City Southern receives new superior offer. Three new bank mergers announced last week. For further details see: Merger Arbitrage Mondays - Bank Mergers Dominate

A big merger at the intersection of the marijuana and pharmaceutical industries is one step closer to completion. On Friday, shareholders of GW Pharmaceuticals (NASDAQ: GWPH) approved its acquisition by a subsidiary of Jazz Pharmaceuticals (NASDAQ: JAZZ) , both companies ann...

GW Pharmaceuticals (GWPH) shareholders have approved the $7.2B acquisition of the company by Jazz Pharmaceuticals (JAZZ).The High Court of Justice of England and Wales will hold a hearing on May 5 to OK the deal, after which the acquisition will be complete.GW closed up 0.2% to...

LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (Jazz) today announced that GW’s shareholders voted to approve the acquisition of GW by a subsidiary of Jazz (or its nominee(s)) at the GW shar...

Investing in Canadian Marijuana Stocks In 2021 In 2021 top Canadian marijuana stocks have seen the most volatility in the market. After seeing upward momentum in January and February leading Canadian cannabis stocks have since suffered substantial losses in market value. As it stand...

Jazz Pharmaceuticals (JAZZ) prices $1.5 billion principal amount of 4.375% senior secured notes due 2029 by Jazz Securities Designated Activity Company, a direct wholly owned subsidiary of the company. Notes will mature on January 15, 2029 and will bear an interest rate of 4.375%. Offeri...

Jazz Pharmaceuticals Prices $1.5 Billion Senior Secured Notes Offering PR Newswire DUBLIN , April 22, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company" or "Jazz") today announced the pricing of the previously announced offering (the...

Jazz Pharmaceuticals' (JAZZ) wholly owned subsidiary, Jazz Securities Designated Activity Company is commencing a private offering of senior secured notes. Net proceeds will be used to fund acquisition of GW Pharmaceuticals and refinancing certain indebtedness.There can be no assurance that e...

Jazz Pharmaceuticals Announces Proposed Private Offering of Senior Secured Notes PR Newswire DUBLIN , April 20, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (the "Company") announced today that its wholly owned subsidiary, Jazz Securities Des...